Innovative Targeted and Immune-Mediated Cancer Therapies
Pipeline
Developing first-in-class small molecule product candidates with broad potential benefit to patients
Science
Modulating validated and new pathways to develop novel therapeutics
News
March 22,
2023
Tempest Reports Year End 2022 Financial Results and Provides Business Update
March 15,
2023
Tempest to Present Biomarker Data for TPST-1120 at the Society for Immunotherapy of Cancer (SITC) 2023 Spring Scientific Meeting
March 14,
2023
Tempest to Present New Translational and Preclinical Data at the 2023 AACR Annual Meeting
Events
Tuesday,
November 29TH,
2022
at
11:30 AM
Eastern
Piper Sandler 34th Annual Healthcare Conference
Listen: Webcast
Monday,
September 12TH,
2022
at
7:00 AM
Eastern
H.C. Wainwright 24th Annual Global Investment Conference
Listen: Webcast
Sunday,
June 5TH,
2022
at
7:30 AM
Eastern
Tempest Investor Breakfast at 2022 ASCO Annual Meeting
Listen: Webcast
Download: Tempest Investor Breakfast at 2022 ASCO Annual Meeting Presentation [pdf]
Monday,
March 29TH,
2021
at
8:30 AM
Eastern
Tempest and Millendo Proposed Merger Investor Call
Listen: Webcast
Download: Proposed Merger of Tempest and Millendo [pdf]